Patterns of early life somatic growth in infants and children with a history of chronic lung disease of prematurity.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
09 2023
Historique:
revised: 30 05 2023
received: 06 03 2023
accepted: 11 06 2023
medline: 21 8 2023
pubmed: 23 6 2023
entrez: 23 6 2023
Statut: ppublish

Résumé

Preterm infants, and especially those with additional comorbidities, are at risk of early life growth failure, which may impact postnatal lung growth and attainment of peak lung function. However, little is known about the early life growth patterns of those with chronic lung disease. The goal of this study was to describe the patterns appreciated in this population and their association with certain clinical characteristics. Demographic, clinical characteristics, and somatic growth parameters between birth and 3 years were retrospectively reviewed for a cohort of children (n = 616) recruited from an outpatient pulmonary clinic. Group-based trajectory modeling was used to identify unique longitudinal trajectories for each growth parameter. Demographic and clinical characteristics were compared using nonparametric analysis. Four distinct trajectories were appreciated in all three somatic growth domains (weight, length, and weight-for-length), which demonstrated a sizable proportion of subjects with a z-score below zero at 36 months of age, suggesting that the traditional preterm paradigm of "catch-up" growth may not be accurate for this population. Children with a history of chronic lung disease begin life with somatic growth measurements well below their term peers and display heterogeneous patterns of weight and length growth through the first 3 years of life. Future studies should focus on further understanding the relationship between somatic growth and respiratory outcomes in this population, which will ideally allow for the use of somatic growth measures as surrogate markers to identify individuals at the highest risk of postnatal growth failure and poor respiratory outcomes.

Identifiants

pubmed: 37350365
doi: 10.1002/ppul.26560
pmc: PMC10576865
mid: NIHMS1928503
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2592-2599

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003099
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114800
Pays : United States

Informations de copyright

© 2023 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.

Références

Lancet Respir Med. 2018 Jul;6(7):535-544
pubmed: 29628376
Pediatrics. 2018 May;141(5):
pubmed: 29622720
Child Dev. 1999 Sep-Oct;70(5):1181-96
pubmed: 10546339
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Am J Respir Crit Care Med. 2010 May 15;181(10):1093-7
pubmed: 20133928
Annu Rev Clin Psychol. 2010;6:109-38
pubmed: 20192788
Ann Nutr Metab. 2014;65(2-3):205-10
pubmed: 25413659
J Pediatr. 1981 Apr;98(4):597-602
pubmed: 7205491
Thorax. 1982 Aug;37(8):564-71
pubmed: 7179184
Pediatr Pulmonol. 2000 Oct;30(4):282-90
pubmed: 11015127
Thorax. 2013 Aug;68(8):760-6
pubmed: 23604458
N Engl J Med. 1967 Feb 16;276(7):357-68
pubmed: 5334613
J Pediatr. 2005 Apr;146(4):469-73
pubmed: 15812448
BMC Pediatr. 2003 Jul 8;3:6
pubmed: 12848901
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Arch Dis Child. 1983 Oct;58(10):791-4
pubmed: 6639126
BMC Pulm Med. 2017 Jun 30;17(1):97
pubmed: 28666441
Natl Health Stat Report. 2013 Feb 11;(63):1-3
pubmed: 24992748
J Cyst Fibros. 2023 May;22(3):395-401
pubmed: 36858852
NCHS Data Brief. 2020 Oct;(387):1-8
pubmed: 33054913
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619892492
pubmed: 31818194
Lancet Child Adolesc Health. 2018 May;2(5):350-359
pubmed: 30169268
Thorax. 1997 Sep;52(9):820-7
pubmed: 9371217
Pediatr Pulmonol. 2021 Nov;56(11):3499-3508
pubmed: 33729686
Nutr Clin Pract. 2022 Apr;37(2):282-298
pubmed: 35124845

Auteurs

Brianna C Aoyama (BC)

Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Sharon A McGrath-Morrow (SA)

Division of Pediatric Pulmonology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Kevin J Psoter (KJ)

Division of General Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Joseph M Collaco (JM)

Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH